<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01779141</url>
  </required_header>
  <id_info>
    <org_study_id>PL01</org_study_id>
    <nct_id>NCT01779141</nct_id>
  </id_info>
  <brief_title>Orchestra Pregnancy Observational Study in Poland</brief_title>
  <official_title>A Multi-center Observational Study During Pregnancy for Women With T1DM Treated With the Paradigm Insulin Pumps Donated by the 'Wielka Orkiestra Świątecznej Pomocy' Foundation in Poland</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Diabetes</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic Poland Spółka z ograniczoną odpowiedzialnością</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Medtronic Diabetes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this project is to document the use of insulin pump therapy (CSII), including
      sensor augmented pump therapy (SAP), before, during and after pregnancy in women with type 1
      Diabetes Mellitus benefiting from the Orchestra donation of Paradigm REAL-Time and Paradigm
      Veo pumps in Poland.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The project is designed as a multi-center prospective observational Post-Market-Release study
      to be conducted in up to 30 centers in Poland.

      Total duration of the study per patient will be up to 22 months (up to 12 months
      pre-conception phase, pregnancy, and 6 weeks after delivery). The optimal study start is the
      beginning of pre-conception phase, however, pregnant women up to the 16th week of pregnancy
      can participate in the study too. The study end is 6 weeks after delivery. If conception does
      not occur within 12-months, the patient's study participation is terminated, and the insulin
      pump might be taken away from the patient. The following therapy is decided by the
      investigator. If the pump is not taken away after the 12-month of trial period for
      conception, the patient can continue insulin pump therapy until the pump is needed for
      another patient.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">August 2017</completion_date>
  <primary_completion_date type="Actual">August 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>22 Months</target_duration>
  <primary_outcome>
    <measure>HbA1c and Continuous Glucose Monitoring data</measure>
    <time_frame>22 months</time_frame>
    <description>To assess the benefits of CSII, including SAP, on the maternal glycemic control</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of prevalence of pregnancy complications and neonatal outcomes</measure>
    <time_frame>from preconception phase, throughout pregnancy, during delivery and after delivery during lactation phase (up to 6 weeks)</time_frame>
    <description>To assess the prevalence of pregnancy complications and neonatal outcomes with the usage of CSII, including SAP</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">481</enrollment>
  <condition>Type 1 Diabetes Mellitus</condition>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>CSII, including SAP</arm_group_label>
    <description>The devices to be used in the study are the Paradigm REAL-Time (722) insulin pump, including the sensor augmented Paradigm® Veo (754) system (insulin pump + Enlite sensor + MiniLink transmitter);</description>
  </arm_group>
  <biospec_retention>None Retained</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood, serum, urine samples as required in routine practice before, during and after
      pregnancy in women with Type 1 Diabetes Mellitus
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The study subject population is women with Type 1 Diabetes Mellitus at the age of 18-45 who

          -  plan pregnancy

          -  are in the early phase of pregnancy, up to the 16th week
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Female diagnosed with Diabetes Mellitus Type 1

          2. Subject indicated by HCP to start insulin pump therapy (CSII) or sensor augmented pump
             therapy (SAP) due to the desired or established pregnancy

          3. HCP has prescribed the use of Orchestra donated device to the subject independently of
             the study

          4. Signed Patient Informed Consent (PIC)

          5. Subject is 18 to 45 years old, planning immediate pregnancy (within the next 12
             months) or being pregnant within the first trimester until the 16th week of amenorrhea

          6. Subject has been on MDI for at least 3 months before starting pump therapy

        Exclusion Criteria:

          1. Subject was enrolled in the registry earlier, and terminated it (for any reason)

          2. Participation in any other interventional clinical trial - currently and/or in the
             last 3 months before the signature of PIC

          3. Subject uses an insulin pump that was not donated by the Orchestra Foundation

          4. Pregnant women with longer than 16 weeks of pregnancy/amenorrhea

          5. Subjects who need assisted in vitro fertilization

          6. Subjects with Diabetes Mellitus Type 2, Gestational Diabetes, MODY or any other type
             of diabetes than Type 1

          7. Subject under the age of 18

          8. Subject legally incompetent

          9. Subject cannot read or write
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jacek Sieradzki, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Cracow Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Uniwersytecki Szpital Kliniczny w Białymstoku</name>
      <address>
        <city>Białystok</city>
        <zip>15-276</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NZOZ Specjalistyczny Ośrodek Internistyczno-Diabetologiczny</name>
      <address>
        <city>Białystok</city>
        <zip>15-435</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Szpital Wojewódzki w Bielsku Białej</name>
      <address>
        <city>Bielsko-Biala</city>
        <zip>43-316</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Szpital Uniwersytecki nr 2 im. dr Jana Biziela w Bydgoszczy</name>
      <address>
        <city>Bydgoszcz</city>
        <zip>85-168</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Szpital Specjalistyczny w Jaśle</name>
      <address>
        <city>Jaslo</city>
        <zip>38-200</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NZOZ WITAMED Outpatient Diabetes Clinic</name>
      <address>
        <city>Kielce</city>
        <zip>25-035</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Szpital Uniwersytecki w Krakowie</name>
      <address>
        <city>Krakow</city>
        <zip>31-501</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Samodzielny Publiczny Szpital Kliniczny nr 4 Uniwersytetu Medycznego w Lublinie</name>
      <address>
        <city>Lublin</city>
        <zip>20-090</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wojewódzki Szpital Specjalistyczny w Olsztynie</name>
      <address>
        <city>Olsztyn</city>
        <zip>10-561</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PSZOZ Wojewódzkie Centrum Medyczne w Opolu</name>
      <address>
        <city>Opole</city>
        <zip>45-418</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zakład Opieki Zdrowotnej Poznań-Jeżyce</name>
      <address>
        <city>Poznan</city>
        <zip>60-834</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinic of Gynecology and Obstetrics of Marcinkowski Medical University</name>
      <address>
        <city>Poznań</city>
        <zip>60-535</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Szpital Wojewódzki nr 2 im. Św. Jadwigi Królowej</name>
      <address>
        <city>Rzeszow</city>
        <zip>35-301</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Samodzielny Publiczny Wojewódzki Szpital Zespolony w Szczecinie im. Marii Skłodowskiej-Curie</name>
      <address>
        <city>Szczecin</city>
        <zip>71-455</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wojewódzki Szpital Zespolony im. L. Rydygiera</name>
      <address>
        <city>Torun</city>
        <zip>87-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Szpital Kliniczny im. ks. Anny Mazowieckiej Warszawskiego Uniwersytetu Medycznego</name>
      <address>
        <city>Warszawa</city>
        <zip>00-315</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Samodzielny Publiczny Centralny Szpital Kliniczny w Warszawie</name>
      <address>
        <city>Warszawa</city>
        <zip>02-097</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mazowiecki Szpital Wojewódzki Sp. z o.o.</name>
      <address>
        <city>Warszawa</city>
        <zip>03-242</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wojewódzki Zespół Specjalistycznej Opieki Zdrowotnej</name>
      <address>
        <city>Wroclaw</city>
        <zip>50-403</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Samodzielny Publiczny Szpital Kliniczny nr 1 im prof. Stanisława Szyszko</name>
      <address>
        <city>Zabrze</city>
        <zip>41-800</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zespół Wojewódzkich Przychodni Specjalistycznych w Katowicach</name>
      <address>
        <city>Zabrze</city>
        <zip>41-800</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NZOZ MED-ART Poradnie Specjalistyczne Sp. z o.o.</name>
      <address>
        <city>Zory</city>
        <zip>44-240</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Uniwersytecki Szpital Kliniczny nr 1 im. Norberta Barlickiego Uniwersytetu Medycznego w Łodzi</name>
      <address>
        <city>Łódź</city>
        <zip>90-153</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Uniwersytet Medyczny w Łodzi, Klinika Diabetologii</name>
      <address>
        <city>Łódź</city>
        <zip>93-338</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 28, 2013</study_first_submitted>
  <study_first_submitted_qc>January 28, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 30, 2013</study_first_posted>
  <last_update_submitted>March 7, 2018</last_update_submitted>
  <last_update_submitted_qc>March 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Type 1 Diabetes Mellitus - T1DM</keyword>
  <keyword>Pregnancy</keyword>
  <keyword>Insulin Pump</keyword>
  <keyword>Glucose Sensor</keyword>
  <keyword>Continuous Subcutaneous Insulin Infusion - CSII</keyword>
  <keyword>Sensor Augmented Pump - SAP</keyword>
  <keyword>Continuous Glucose Monitoring - CGM</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

